"Allergy & Asthma Specialists, PSC specializes in the diagnosis and treatment of allergic disease, asthma and immunologic disorders. Allergy & Asthma Specialists strives to provide the utmost quality and patient-focused care, while promoting continuous quality improvement. We have provided care to the residents of Owensboro and surrounding region for more than 20 years."

During the past decade, Allergy & Asthma Specialists, PSC conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Allergy & Asthma Specialists, PSC" #1 sponsor was "Celldex Therapeutics" with 2 trials, followed by "GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc." with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored, "Regeneron Pharmaceuticals" with 1 trials sponsored and "Stallergenes Greer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Allergy & Asthma Specialists, PSC" #1 collaborator was "Sanofi" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Allergy & Asthma Specialists, PSC" are "Asthma" (2 trials), "Allergic Rhinitis Due to Grass Pollens" (1 trials), "Chronic Inducible Urticaria" (1 trials), "Chronic Spontaneous Urticaria" (1 trials) and "Urticaria" (1 trials). Many other conditions were trialed in "Allergy & Asthma Specialists, PSC" in a lesser frequency.

Most popular intervention types in "Allergy & Asthma Specialists, PSC" are "Drug" (6 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Matching Placebo" (2 trials), "barzolvolimab" (2 trials), "300 IR" (1 trials) and "DUPIXENT®" (1 trials). Other intervention names were less common.

The vast majority of trials in "Allergy & Asthma Specialists, PSC" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Allergy & Asthma Specialists, PSC". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Allergy & Asthma Specialists, PSC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Allergy & Asthma Specialists, PSC, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".